Innovations in Microbiome, Small Molecules, Biologics, and Biotech Platforms

Innovations in Microbiome, Small Molecules, Biologics, and Biotech Platforms

RELEASE DATE
19-Jul-2019
REGION
Global
Research Code: D759-00-0A-00-00
SKU: HC03197-GL-TA_23411
$950.00
In stock
SKU
HC03197-GL-TA_23411
$950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Ths edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) 26 innovation stories across microbiome, small molecules, infectious disease diagnostics, biologics, and several other biotech platforms. The TOE also provides technological, application and megatrends impact, apart from exclusive analyst insights across each technology platform.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Viome, artificial intelligence, mega trends, disruption, microbiome, Watercress, superfood, dysbiosis, Ixcela, probiotics, precision medicine, DayTwo, glycemia, Targedys, Nanopore, Sequencing, Daktari, diagnostic, inui, smartphone, viral vector, gene delivery, B-MoGen, Forty Seven, check-point inhibitor, Genocea, immunology, cancer, Gritstone, Autolus, Arcus, MODAG, multiple system atrophy, Encoded, gene therapy, Adaptive, Dundee, Protac, SAGA, liquid biopsy, MedRhythms, BlackThorn, Genome Medical, Fractyl Labs, Refuge, cell therapies, Excision BioTherapeutics, gene editing, Poxel, Imeglimin

Table of Contents

Recent Advances in Small Molecules, Biologics and Microbiome Technologies

  • Viome Inc.
  • Viome Inc.
  • The Watercress Company
  • The Watercress Company
  • Ixcela Inc.
  • Ixcela Inc.
  • DayTwo
  • DayTwo
  • TargEDys
  • TargEDys
  • Oxford Nanopore Technologies Limited
  • Oxford Nanopore Technologies Limited
  • Daktari Diagnostics Inc.
  • Daktari Diagnostics Inc.
  • inui Health
  • inui Health
  • B-MoGen Biotechnologies Inc.
  • B-MoGen Biotechnologies Inc.
  • Forty Seven Inc.
  • Forty Seven Inc.
  • Genocea Biosciences Inc.
  • Genocea Biosciences Inc.
  • Gritstone Oncology
  • Gritstone Oncology
  • Autolus Therapeutics plc
  • Autolus Therapeutics plc
  • Arcus Biosciences
  • Arcus Biosciences
  • MODAG
  • MODAG
  • Encoded Therapeutics
  • Encoded Therapeutics
  • Adaptive Biotechnologies Corporation
  • Adaptive Biotechnologies Corporation
  • University of Dundee
  • University of Dundee
  • SAGA Diagnostics
  • SAGA Diagnostics
  • MedRhythms
  • MedRhythms
  • BlackThorn Therapeutics
  • BlackThorn Therapeutics
  • Genome Medical
  • Genome Medical
  • Fractyl Labs
  • Fractyl Labs
  • Refuge Biotechnologies
  • Refuge Biotechnologies
  • Excision BioTherapeutics
  • Excision BioTherapeutics
  • Poxel
  • Poxel

Appendix

  • Key Contacts
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Your F&S Thought Leader
Related Research
Ths edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) 26 innovation stories across microbiome, small molecules, infectious disease diagnostics, biologics, and several other biotech platforms. The TOE also provides technological, application and megatrends impact, apart from exclusive analyst insights across each technology platform. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Viome, artificial intelligence, mega trends, disruption, microbiome, Watercress, superfood, dysbiosis, Ixcela, probiotics, precision medicine, DayTwo, glycemia, Targedys, Nanopore, Sequencing, Daktari, diagnostic, inui, smartphone, viral vector, gene delivery, B-MoGen, Forty Seven, check-point inhibitor, Genocea, immunology, cancer, Gritstone, Autolus, Arcus, MODAG, multiple system atrophy, Encoded, gene therapy, Adaptive, Dundee, Protac, SAGA, liquid biopsy, MedRhythms, BlackThorn, Genome Medical, Fractyl Labs, Refuge, cell therapies, Excision BioTherapeutics, gene editing, Poxel, Imeglimin
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-0A-00-00
Is Prebook No
Ti Codes D759,D904,D913,D91A,D91B,D932,D933,D935,D936,D937